FrancophonIA/ELRC3.0 huggingface dataset:
English: Check to see if the status light is SOLID GREEN or has switched off.
Croatian: Provjerite svijetli li statusna lampica NEPREKIDNIM ZELENIM SVJETLOM ili ako se ugasila.
English: Each pack contains 1 glass pre-filled syringe with an attached stainless steel needle and needle cap.
Croatian: U svakom pakiranju nalazi se 1 napunjena staklena štrcaljka s pripojenom iglom od nehrđajućeg čelika i kapicom za iglu.
English: Glomerulonephritis has been reported in patients receiving filgrastim and pegfilgrastim.
Croatian: Prijavljen je glomerulonefritis u bolesnika koji su primali filgrastim i pegfilgrastim.
English: If it is flashing red, contact your healthcare provider immediately.
Croatian: Ako svijetli crveno, odmah obavijestite svog zdravstvenog radnika.
English: If you have an allergic reaction during the delivery of Neulasta, remove the on-body injector by grabbing the edge of the adhesive pad and peeling off the on-body injector.
Croatian: Ako se tijekom primjene Neulaste pojavi alergijska reakcija, uklonite on-body injektor povlačenjem ruba ljepljive podloge kako biste ga odlijepili.
English: Do not put the grey needle cap back on used pre-filled syringes.
Croatian: Ne vraćajte sivu kapicu za iglu na iskorištenu napunjenu štrcaljku.
English: Remove and save the pre-filled syringe label.
Croatian: Odlijepite i sačuvajte naljepnicu s napunjene štrcaljke.
English: What do I do if the on-body injector comes off before the full dose is delivered?
Croatian: Što učiniti ako se on-body injektor odvoji prije nego što primite cijelu dozu?
English: • Tell your doctor if you have an allergy to latex.
Croatian: • Obavijestite svog liječnika ukoliko ste alergični na lateks.
English: Treatment with pegfilgrastim alone does not preclude thrombocytopenia and anaemia because full dose myelosuppressive chemotherapy is maintained on the prescribed schedule.
Croatian: Liječenje pegfilgrastimom u monoterapiji ne isključuje razvoj trombocitopenije niti anemije uslijed liječenja punom dozom mijelosupresivne kemoterapije prema propisanom rasporedu.
English: You do not have to remove the air bubble before injecting.
Croatian: Ne morate uklanjati mjehuriće zraka prije injiciranja.
English: In all cases, call your doctor or healthcare provider.
Croatian: U svim navedenim slučajevima, obratite se svom liječniku ili zdravstvenom djelatniku.
English: In a phase II (n = 37) multicentre, randomised, open-label study of paediatric sarcoma patients receiving 100 mcg/kg pegfilgrastim following cycle 1 of vincristine, doxorubicin and cyclophosphamide (VAdriaC/IE) chemotherapy, a longer duration of severe neutropenia (neutrophils < 0.5 x 10
Croatian: U fazi II (n = 37) multicentričnog, randomiziranog, otvorenog ispitivanja pedijatrijskih bolesnika sa sarkomom koji su primali 100 μg/kg pegfilgrastima nakon 1. ciklusa kemoterapije vinkristinom, doksorubicinom i ciklofosfamidom (VAdriaC/IE) uočeno je dulje trajanje teške neutropenije (neutrofili < 0,5 x 10
English: The rate (Cmax) and extent (AUC0-inf) of the absorption of pegfilgrastim delivered by the on-body injector were similar to those from the manual injection of the pre-filled syringe.
Croatian: Brzina (Cmax) i trajanje (AUC0-inf) apsorpcije pegfilgrastima primijenjenog on-body injektorom bili su slični onima kod injekcije napunjenom štrcaljkom primjenjenom ručno.
English: The Neulasta pre-filled syringe for manual administration must not be used with the on-body injector.
Croatian: Neulasta napunjena štrcaljka za ručnu primjenu ne smije se upotrebljavati s on-body injektorom.
English: Step 2: Monitor Dose Delivery
Croatian: Korak 2: Pratite primjenu doze
English: Pack size of one.
Croatian: Pakiranje od jedne štrcaljke.
English: On-body injector becomes loose or falls off
Croatian: On-body injektor je labav ili je otpao
English: • If medicine has leaked or the adhesive is noticeably wet (saturated), contact your healthcare provider immediately as you may not have received your full dose and you may need a replacement dose.
Croatian: • Ako je lijek iscurio ili ako je ljepljiva podloga vidno mokra (natopljena), odmah obavijestite svog zdravstvenog radnika jer možda niste dobili cijelu dozu; možda ćete trebati nadomjesnu dozu.
English: Hypersensitivity reactions;
Croatian: Reakcije preosjetljivosti; Anafilaksija
English: • allergic-type reactions, including redness and flushing, skin rash, and raised areas of the skin that itch.
Croatian: • reakcije alergijskog tipa, uključujući crvenilo i navale crvenila, osip na koži, izdignuta područja kože koja svrbe.
English: The incidence of hospitalisations and IV anti-infective use associated with a clinical diagnosis of febrile neutropenia was lower in the pegfilgrastim group compared with placebo (1% versus 14%, p < 0.001; and 2% versus 10%, p < 0.001).
Croatian: Incidencija bolničkog liječenja i intravenske primjene antiinfektivnih lijekova, povezanog s kliničkom dijagnozom febrilne neutropenije, bila je niža u skupini liječenoj pegfilgrastimom nego u skupini koja je primala placebo (1% prema 14%, p < 0,001 te 2% prema 10%, p < 0,001).
English: Contact dermatitis and local skin reactions such as rash, pruritus, and urticaria have been reported with the use of the on-body injector, possibly indicating a hypersensitivity reaction to the adhesive.
Croatian: Kontaktni dermatitis i kožne reakcije poput osipa, svrbeža i urtikarije prijavljeni su kod uporabe on-body injektora, što može upućivati na reakciju preosjetljivosti na adhezijsko sredstvo.
English: Once filled, the on-body injector should be used for immediate application and can be applied on the same day as the administration of cytotoxic chemotherapy, as long as application is timed to ensure the on-body injector delivers Neulasta at least 24 hours after administration of cytotoxic chemotherapy.
Croatian: Nakon što se napuni, on-body injektor treba primijeniti odmah i može ga se primijeniti na dan primjene citotoksične kemoterapije, ali pod uvjetom da je primjena vremenski regulirana kako bi se osiguralo da on-body injektor primjeni lijek Neulasta najmanje 24 sata nakon primjene citotoksične kemoterapije.
English: Due to the potential sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy‚ pegfilgrastim should be administered at least 24 hours after administration of cytotoxic chemotherapy.
Croatian: Zbog moguće osjetljivosti brzo dijelećih mijeolidnih stanica na citotoksičnu kemoterapiju, pegfilgrastim treba primijeniti najmanje 24 sata nakon primjene citotoksične kemoterapije.
English: Injection site reactions, including injection site erythaema (uncommon) as well as injection site pain (common) have occurred on initial or subsequent treatment with pegfilgrastim.
Croatian: Reakcije na mjestu injiciranja, uključujući eritem na mjestu injiciranja (manje često) kao i bol na mjestu injiciranja (često) javljale su se prilikom prvog ili sljedećeg liječenja pegfilgrastimom.
English: Remember, any time you see a status light flashing red, call your healthcare provider immediately, as you may need a replacement dose.
Croatian: Upamtite, kad god vidite da statusna lampica svijetli crveno, odmah obavijestite svog zdravstvenog radnika jer ćete možda trebati nadomjesnu dozu.
English: • Keep the on-body injector dry for the last 3 hours prior to the start of dose delivery.
Croatian: • Održavajte on-body injektor suhim najmanje 3 sata prije početka dobivanja lijeka.
English: Permanently discontinue pegfilgrastim in patients with clinically significant hypersensitivity.
Croatian: Liječenje pegfilgrastimom se mora trajno prekinuti u bolesnika koji razviju klinički značajnu preosjetljivost.
English: The on-body injector should be applied to intact, non-irritated skin on the back of the arm or abdomen.
Croatian: On-body injektor potrebno je primijeniti na neoštećenu, neiritiranu kožu stražnjeg dijela nadlaktice ili abdomena.
English: These have generally occurred in patients with advanced malignant diseases, sepsis, taking multiple chemotherapy medications or undergoing apheresis (see section 4.4).
Croatian: Obično su se javili u bolesnika s uznapredovalom malignom bolesti, sepsom, bolesnika koji su uzimali kemoterapiju s više lijekova ili bolesnika na aferezi (vidjeti dio 4.4).
English: Pre-filled syringe (Type I glass), with a rubber stopper, stainless steel needle and needle cap with or without an automatic needle guard.
Croatian: Napunjena štrcaljka (staklo tipa I), s gumenim čepom, iglom od nehrđajućeg čelika i kapicom za iglu sa ili bez automatskog štitnika za iglu.
English: This medicine contains less than 1 mmol (23 mg) sodium per 6 mg dose, that is to say essentially ‘sodium-free'.
Croatian: Ovaj lijek sadrži manje od 1 mmol (23 mg) natrija na 6 mg doze, odnosno sadrži zanemarive količine natrija.
English: Do not rub the injection site.
Croatian: Ne trljajte mjesto injiciranja.
English: Over the entire study, the rate of febrile neutropenia was 13% of pegfilgrastim-treated patients compared with 20% of filgrastim-treated patients (difference 7%, 95% CI of -19%, 5%).
Croatian: Tijekom cijelog ispitivanja stopa febrilne neutropenije u bolesnika liječenih pegfilgrastimom iznosila je 13%, a 20% u bolesnika liječenih filgrastimom (razlika 7%, 95% CI od -19%, 5%).
English: Uncommonly, cases have resulted in respiratory failure or ARDS, which may be fatal (see section 4.4).
Croatian: Manje često su ovi slučajevi rezultirali respiratornim zatajenjem ili ARDS-om, koji mogu imati smrtni ishod (vidjeti dio 4.4).
English: NL-4817 ZK Breda The Netherlands
Croatian: NL-4817 ZK Breda Nizozemska
English: Keep the syringe and sharps disposal container out of sight and reach of children.
Croatian: Čuvajte štrcaljku i spremnik za odlaganje oštrih predmeta daleko od pogleda i dohvata djece.
English: Neulasta contains sorbitol (E420) and sodium acetate
Croatian: Neulasta sadrži sorbitol (E420) i natrijev acetat
English: • Tell your healthcare provider if you have an allergy to latex.
Croatian: • Obavijestite svog zdravstvenog radnika ako ste alergični na lateks.
English: • application site reactions which may include redness, bleeding, bruising, pain and discomfort have been seen with the on-body injector.
Croatian: • reakcije na mjestu primjene koje mogu uključivati crvenilo, krvarenje, nastanak krvnih podljeva, bol i nelagodu, opažene su kod uporabe on-body injektora.
English: • if you experience an allergic reaction including weakness, drop in blood pressure, difficulty breathing, swelling of the face (anaphylaxis), redness and flushing, skin rash and areas of the skin that itch.
Croatian: • ako imate alergijsku reakciju koja uključuje slabost, pad krvnog pritiska, otežano disanje, oticanje lica (anafilaksa), crvenilo i navale crvenila, osip na koži ili područja kože koja svrbe;
English: Do not attempt to remove the clear pre-filled syringe safety guard from the pre-filled syringe.
Croatian: Ne pokušavajte ukloniti prozirni sigurnosni štitnik štrcaljke s napunjene štrcaljke.
English: Syringe label Syringe barrel Syringe safety guard
Croatian: Hvatište za prste Naljepnica na štrcaljki Spremnik štrcaljke Sigurnosni štitnik štrcaljke
English: The needle cap of the pre-filled syringe contains dry natural rubber (a derivative of latex) (see section 4.4).
Croatian: Pokrov igle napunjene štrcaljke sadrži suhu prirodnu gumu (derivat lateksa) (vidjeti dio 4.4).
English: The incidence of febrile neutropenia was lower for patients randomised to receive pegfilgrastim compared with placebo (1% versus 17%, p < 0.001).
Croatian: Incidencija febrilne neutropenije bila je niža u bolesnica randomiziranih u grupu koja je dobivala pegfilgrastima u usporedbi s bolesnicama koje su dobivale placebo (1% prema 17%, p < 0,001).
English: - Whilst wearing the Neulasta on body injector it is important that you keep the Alert Card provided by your doctor, pharmacist or nurse with you.
Croatian: Pogledajte dio 4. - Važno je da za vrijeme nošenja Neulasta on-body injektora (injektora koji se pričvrščuje na kožu) kod sebe imate karticu s upozorenjima za bolesnika koju Vam je dao Vaš liječnik, ljekarnik ili medicinska sestra.
English: The on-body injector uses acrylic adhesive and may result in an allergic reaction.
Croatian: On-body injektor koristi adhezijsko sredstvo od akrila koje može uzrokovati alergijsku reakciju;
English: If the pre-filled syringe co-packed with the on-body injector is used for manually administering a subcutaneous injection, the patient will receive more than the recommended dose.
Croatian: Ako se napunjena štrcaljka priložena u pakiranju s on-body injektorom upotrebljava za ručnu primjenu supkutane injekcije, bolesnik će primiti veću dozu od preporučene.
English: Contact your healthcare provider immediately if you experience persistent or worsening redness or tenderness at the application site, as this can be a sign of infection.
Croatian: Odmah obavijestite svog zdravstvenog radnika ako se pojavi ustrajno ili pogoršavajuće crvenilo ili osjetljivost mjesta injiciranja jer to može biti znak infekcije.
English: For further instructions on how to inject yourself with Neulasta, please read the section at the end of this leaflet.
Croatian: Dodatne upute o tome kako samostalno injicirati lijek Neulasta potražite u dijelu na kraju ove upute o lijeku.
English: A small (n = 83), Phase II, randomised, double-blind study in patients receiving chemotherapy for de novo acute myeloid leukaemia compared pegfilgrastim (single dose of 6 mg) with filgrastim, administered during induction chemotherapy.
Croatian: U malom (n = 83), randomiziranom, dvostruko slijepom ispitivanju faze II, u bolesnika s de novo akutnom mijeloičnom leukemijom liječenih kemoterapijom uspoređivan je pegfilgrastim (pojedinačna doza od 6 mg) s filgrastimom, primjenjivanima tijekom indukcijske kemoterapije.
English: • Do not expose the on-body injector to the following because the on-body injector may be damaged and you could be injured: - Diagnostic imaging (e.g. CT scan, MRI, ultrasound, x-ray).
Croatian: • Ne izlažite on-body injektor sljedećem jer se može oštetiti, a Vi ozlijediti: Dijagnostičke slikovne pretrage (npr. CT, MR, ultrazvuk, rendgen). radioterapija. okruženja bogata kisikom, kao što su hiperbarične komore (transparentna komora s povišenim atmosferskim tlakom).
English: Pack size of one pre-filled syringe, in either blistered or non-blistered packaging.
Croatian: Veličina pakiranja od jedne napunjene štrcaljke koja može biti ili u blisteru ili u pakiranju bez blistera.
English: If the pre-filled syringe for manual administration is used with the on-body injector, the patient may receive less than the recommended dose.
Croatian: Ako se napunjena štrcaljka za ručnu primjenu upotrebljava s on-body injektorom, bolesnik može primiti manju dozu od preporučene.
English: 4817 ZK Breda The Netherlands
Croatian: 4817 ZK Breda Nizozemska
English: Contact your healthcare provider immediately if the on-body injector comes away from your skin at any time before your full dose has been delivered.
Croatian: Odmah obavijestite svog zdravstvenog radnika ako se on-body injektor u bilo kojem trenutku odvoji od Vaše kože prije nego što ste primili cijelu dozu.
English: If you have any concerns or further questions on the use of this medicine, contact your healthcare provider.
Croatian: Ako imate dodatnih pitanja u vezi s uporabom ovog lijeka, obratite se svom zdravstvenom radniku.
English: Do not remove the grey needle cap from the pre-filled syringe until you are ready to inject.
Croatian: Ne uklanjajte sivu kapicu igle s napunjene štrcaljke sve dok niste spremni injicirati.
English: • Contact your healthcare provider immediately if you experience persistent or worsening redness or tenderness at the application site, as this can be a sign of infection.
Croatian: • Odmah obavijestite svog zdravstvenog radnika ako se pojavi ustrajno ili pogoršavajuće crvenilo ili osjetljivost mjesta injiciranja jer ovo može biti znak upale.
English: Do not grasp the plunger.
Croatian: Ne hvatajte klip.
English: Marketing Authorisation Holder and Manufacturer Amgen Europe B.V.
Croatian: Nositelj odobrenja za stavljanje lijeka u promet i proizvođač Amgen Europe B.V.
English: In a placebo-controlled, double blind study in patients with breast cancer the effect of pegfilgrastim on the incidence of febrile neutropenia was evaluated following administration of a chemotherapy regimen associated with a febrile neutropenia rate of 10-20% (docetaxel 100 mg/m every 3 weeks for
Croatian: U placebo kontroliranom, dvostruko slijepom ispitivanju provedenom u bolesnica s karcinomom dojke, ispitivan je učinak pegfilgrastima na incidenciju pojave febrilne neutropenije nakon primjene kemoterapijskog režima povezanog s razvojem febrilne neutropenije sa stopom od 10-20% (docetaksel 100 mg/m svaka 3 tjedna tijekom 4 ciklusa).
English: Pulmonary adverse reactions, in particular interstitial pneumonia, have been reported after G-CSF administration.
Croatian: Plućne nuspojave, posebice intersticijska upala pluća, prijavljene su nakon primjene faktora stimulacije rasta granulocita (G-CSF).
English: • Contact your healthcare provider immediately as you may not have received your full dose and may need a replacement dose.
Croatian: • Odmah obavijestite svog zdravstvenog radnika jer možda niste primili cijelu dozu; možda ćete trebati nadomjesnu dozu.
English: • cutaneous vasculitis (inflammation of the blood vessels in the skin).
Croatian: • kožni vaskulitis (upala krvnih žila kože).
English: • Avoid knocking or pulling the on-body injector.
Croatian: • Izbjegavajte udaranje ili povlačenje on-body injektora.
English: Then LIFT the syringe off skin.
Croatian: Zatim ODVOJITE štrcaljku od kože.
English: Call your healthcare provider immediately as you may need a replacement dose.
Croatian: Odmah obavijestite svog zdravstvenog radnika jer ćete možda trebati nadomjesnu dozu.
English: Solution for injection (injection) with on-body injector (Onpro kit).
Croatian: Otopina za injekciju (injekcija) s on-body injektorom (Onpro pribor).
English: Do not reuse the pre-filled syringe.
Croatian: Nemojte ponovno upotrebljavati iskorištenu štrcaljku.
English: There is insufficient information on the excretion of pegfilgrastim/metabolites in human milk, a risk to the newborns/infants cannot be excluded.
Croatian: Nema dovoljno podataka o izlučivanju pegfilgrastima/metabolita u majčino mlijeko u ljudi.
English: Healthcare providers only The trade name of the administered product should be clearly recorded in the patient file.
Croatian: Samo za zdravstvene radnike Zaštićeno ime primijenjenog lijeka mora se jasno navesti u bolesnikovoj medicinskoj dokumentaciji.
English: Pegfilgrastim is a sustained duration form of filgrastim due to decreased renal clearance.
Croatian: Pegfilgrastim je oblik filgrastima produljenog djelovanja uslijed smanjenog bubrežnog klirensa.
English: Sickle cell crises have been associated with the use of pegfilgrastim in patients with sickle cell trait or sickle cell disease (see section 4.8).
Croatian: Krize srpastih stanica povezane su s primjenom pegfilgrastima u bolesnika koji imaju nasljedno obilježje srpastih stanica ili bolest srpastih stanica (vidjeti dio 4.8).
English: Due to the neutrophil-mediated clearance mechanism, the pharmacokinetics of pegfilgrastim is not expected to be affected by renal or hepatic impairment.
Croatian: Zbog mehanizma klirensa koji posreduju neutrofili ne očekuje se da bi oštećena funkcija jetre ili bubrega utjecala na farmakokinetiku pegfilgrastima.
English: If the on-body injector was placed on the back of your arm, a caregiver must be available to monitor its status.
Croatian: Ako je on-body injektor postavljen na stražnji dio Vaše nadlaktice, njegovatelj mora biti prisutan kako bi pratio status uređaja.
English: The on-body injector uses an acrylic adhesive.
Croatian: On-body injektor koristi adhezijsko sredstvo od akrila.
English: If the on-body injector is not empty, contact your healthcare provider immediately as you may need a replacement dose.
Croatian: Ako on-body injektor nije prazan, odmah obavijestite svog zdravstvenog radnika jer ćete možda trebati nadomjesnu dozu.
English: • Do not use baths, hot tubs, whirlpool baths, or saunas while wearing the on-body injector.
Croatian: • Ne koristite kade, vruće kuplji, hidromasažne kade ili saune tijekom nošenja on-body injektora jer mogu utjecati na Vaš lijek.
English: • if you have any of the following or combination of the following side effects: swelling or puffiness, which may be associated with passing water less frequently, difficulty breathing, abdominal swelling and feeling of fullness, and a general feeling of tiredness.
Croatian: • ako imate znakove jedne od sljedećih ili kombinacije sljedećih nuspojava: oticanje ili podbuhlost, što može biti povezano s rjeđom učestalošću mokrenja, otežano disanje, oticanje trbuha i osjećaj punoće, te opći osjećaj umora.
English: Name and address of the manufacturers responsible for batch release
Croatian: Naziv i adresa proizvođača odgovornih za puštanje serije lijeka u promet
English: Injection site reactions2
Croatian: Reakcije na mjestu injiciranja2
English: This section contains information on how to give yourself an injection of Neulasta.
Croatian: Ovo poglavlje sadrži upute o samoprimjeni injekcije Neulaste.
English: • Upper part of your thigh.
Croatian: • Gornji dio bedra.
English: Do not administer pegfilgrastim to patients with a history of hypersensitivity to pegfilgrastim or filgrastim.
Croatian: Pegfilgrastim se ne smije primjenjivati kod bolesnika s preosjetljivosti na pegfilgrastim ili filgrastim u anamnezi.
English: • a pre-filled syringe with on-body injector for automatic administration.
Croatian: • napunjene štrcaljke s on-body injektorom za automatsku primjenu.
English: In two randomised, double-blind, pivotal studies in patients with high-risk stage II-IV breast cancer undergoing myelosuppressive chemotherapy consisting of doxorubicin and docetaxel, use of pegfilgrastim, as a single once per cycle dose, reduced the duration of neutropenia and the incidence of febrile neutropenia similarly to that observed with daily administrations of filgrastim (a median of 11 daily administrations).
Croatian: U dva randomizirana, dvostruko slijepa, pivotalna ispitivanja u bolesnica s rakom dojke visokog rizika, stadij II-IV podvrgnutih mijelosupresivnoj kemoterapiji koja se sastojala od doksorubicina i docetaksela, primjena pegfilgrastima, u pojedinačnoj dozi jednom po ciklusu, smanjila je trajanje neutropenije i učestalost pojave febrilne neutropenije slično kao dnevna primjena filgrastima (medijan od 11 dnevnih primjena).
English: One 6 mg dose (a single pre-filled syringe) of Neulasta is recommended for each chemotherapy cycle, given at least 24 hours after cytotoxic chemotherapy.
Croatian: Jednokratna doza Neulaste od 6 mg (jedna napunjena štrcaljka) preporučuje se uz svaki kemoterapijski ciklus, najmanje 24 sata nakon primjene citotoksične kemoterapije.
English: In a second study (n = 310), which used a weightadjusted dose (100 mcg/kg), the mean duration of grade 4 neutropenia for the pegfilgrastim group was 1.7 days, compared with 1.8 days in the filgrastim group (difference 0.03 days, 95% CI -0.36, 0.30).
Croatian: U drugom ispitivanju (n=310), u kojemu je primjenjivana doza prilagođena tjelesnoj težini (100 μg/kg), srednje trajanje neutropenije 4. stupnja u skupini liječenoj pegfilgrastimom iznosilo je 1,7 dana, u usporedbi s 1,8 dana u skupini liječenoj filgrastimom (razlika 0,03 dana, 95% CI -0,36, 0,30).
English: • if you get left upper abdominal pain or pain at the tip of your shoulder.
Croatian: • ako osjetite bol u gornjem lijevom dijelu trbuha ili u vrhu ramena.
English: On-body injector for Neulasta 6 mg solution for injection Patient instructions for use
Croatian: On-body injektor za Neulasta 6 mg otopina za injekciju Upute za uporabu za bolesnike
English: For use with the on-body injector only.
Croatian: Samo za uporabu s on-body injektorom
English: How do I prepare my Neulasta injection?
Croatian: Kako se priprema injekcija Neulaste?
English: Common cases of leukocytosis (White Blood Count [WBC] > 100 x 10
Croatian: Prijavljeni su česti slučajevi leukocitoze (broj leukocita > 100 x 10
English: • coughing up blood (haemoptysis).
Croatian: • iskašljavanje krvi (hemoptiza).